Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Rank Network Comparison Type Gene red Filtered green network_comparison
Results: HTML CSV LaTeX
Showing element 294 to 343 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apopain precursor (ec 3.4.22.-) (cysteine protease cpp32) (yama protein) (cpp-32) (caspase-3) (casp-3) (srebp cleavage activity 1) (sca-1). [source:swissprot;acc:p42574]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
949\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4633.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5084.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09728\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apoptosis antagonizing transcription factor. [source:refseq;acc:nm\_012138]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
853\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4078.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4502.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10393\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apoptosis inhibitor 5; fibroblast growth factor 2-interacting factor 2; api5-like 1. [source:refseq;acc:nm\_006595]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
771\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2589\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7181.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7057.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01747\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apoptosis-inducing factor (aif)-homologous mitochondrion-associated inducer of death; p53-responsive gene 3. [source:refseq;acc:nm\_032797]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1496\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5945.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6389.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07469\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
apurinic/apyrimidinic endonuclease 2; apurinic/apyrimidinic endonuclease-like 2; apex nuclease-like 2. [source:refseq;acc:nm\_014481]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1225\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5546.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6019.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08529\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aquaporin 4 (wch4) (mercurial-insensitive water channel) (miwc). [source:swissprot;acc:p55087]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
523\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10640.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12117.8\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.13887\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
aquaporin 5. [source:swissprot;acc:p55064]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
524\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10640\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12117.6\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aquaporin-cd (aqp-cd) (water channel protein for renal collecting duct) (adh water channel) (aquaporin 2) (collecting duct water channel protein) (wch-cd). [source:swissprot;acc:p41181]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
526\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10639.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12117.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13886\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aquaporin-chip (water channel protein for red blood cells and kidney proximal tubule) (aquaporin 1) (aqp-1) (urine water channel). [source:swissprot;acc:p29972]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
528\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10635.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12111.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13879\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arf gtpase-activating protein git1 (g protein-coupled receptor kinase- interactor 1). [source:swissprot;acc:q9y2x7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2219\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5853.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6136.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0484\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arf gtpase-activating protein git2 (g protein-coupled receptor kinase- interactor 2). [source:swissprot;acc:q14161]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2252\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5840.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6113.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04665\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arg/abl-interacting protein 2 isoform 2; arg binding protein 2. [source:refseq;acc:nm\_021069]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
436\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6230.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7168.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15042\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arginase 1 (ec 3.5.3.1) (liver-type arginase). [source:swissprot;acc:p05089]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1852\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6271.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6670.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06375\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arginase ii, mitochondrial precursor (ec 3.5.3.1) (non-hepatic arginase) (kidney-type arginase). [source:swissprot;acc:p78540]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1849\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6267.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6668.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06394\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arginine-glutamic acid dipeptide (re) repeats; atrophin 1-like; arginine glutamic acid dipeptide re repeats. [source:refseq;acc:nm\_012102]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2278\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5783.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6048.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04585\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arginine/serine-rich splicing factor 10 (transformer-2-beta) (htra2- beta) (transformer 2 protein homolog) (silica-induced protein 41) (ra301). [source:swissprot;acc:q15815]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
993\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6499.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7121.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09568\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
argininosuccinate lyase (ec 4.3.2.1) (arginosuccinase) (asal). [source:swissprot;acc:p04424]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1123\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5857.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6380.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08927\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
argininosuccinate synthase (ec 6.3.4.5) (citrulline--aspartate ligase). [source:swissprot;acc:p00966]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1739\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5695.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6079.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06743\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arginyl-trna synthetase-like; arginine-trna ligase. [source:refseq;acc:nm\_020320]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
839\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7093.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7842.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10556\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ariadne-2 protein homolog (ari-2) (triad1 protein) (ht005). [source:swissprot;acc:o95376]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2798\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
armet protein precursor (arginine-rich protein). [source:swissprot;acc:p55145]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
698\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7101.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7949.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11939\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arp2/3 complex 16 kda subunit (p16-arc) (actin-related protein 2/3 complex subunit 5). [source:swissprot;acc:o15511]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1788\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5386.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5744.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06651\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arp2/3 complex 21 kda subunit (p21-arc) (actin-related protein 2/3 complex subunit 3). [source:swissprot;acc:o15145]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1784\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5386.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5744.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06656\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arp2/3 complex 34 kda subunit (p34-arc) (actin-related protein 2/3 complex subunit 2). [source:swissprot;acc:o15144]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1750\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5384.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5746.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06715\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arp2/3 complex 41 kda subunit (p41-arc) (actin-related protein 2/3 complex subunit 1b). [source:swissprot;acc:o15143]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1781\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5386.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5744.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06656\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
arsenical pump-driving atpase (ec 3.6.3.16) (arsenite-translocating atpase) (arsenical resistance atpase) (arsenite-transporting atpase) (arsa) (asna-i). [source:swissprot;acc:o43681]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2525\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8695.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8912.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02505\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aryl-hydrocarbon interacting protein-like 1. [source:swissprot;acc:q9nzn9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1903\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5204.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5530.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06261\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
asc-1 complex subunit p100. [source:refseq;acc:nm\_032204]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1206\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5946.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6459.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08635\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
asparagine synthetase [glutamine-hydrolyzing] (ec 6.3.5.4) (glutamine- dependent asparagine synthetase) (ts11 cell cycle control protein). [source:swissprot;acc:p08243]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
730\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6000.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6696.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
asparaginyl-trna synthetase, cytoplasmic (ec 6.1.1.22) (asparagine-- trna ligase) (asnrs). [source:swissprot;acc:o43776]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2103\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6847.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7223.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05486\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1010\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0948\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aspartyl-trna synthetase (ec 6.1.1.12) (aspartate--trna ligase) (asprs). [source:swissprot;acc:p14868]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2026\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6766.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7155.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0575\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
associated molecule with the sh3 domain of stam (amsh) like protein. [source:refseq;acc:nm\_020799]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
146\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
11068\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8508.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.30082\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
associated molecule with the sh3 domain of stam. [source:refseq;acc:nm\_006463]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
148\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ataxin 2 related protein isoform a; ataxin-2 domain protein. [source:refseq;acc:nm\_007245]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
602\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4864.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5514.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13366\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ataxin 2-binding protein. [source:swissprot;acc:q9nwb1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2117\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5778.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6093.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0546\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ataxin 2; olivopontocerebellar ataxia 2, autosomal dominant. [source:refseq;acc:nm\_002973]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
603\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4864.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5514.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13366\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ataxin-1 ubiquitin-like interacting protein. [source:refseq;acc:nm\_020131]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2645\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9128.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9218.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00989\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
206\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5720.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4577.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24965\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atp synthase alpha chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p25705]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
834\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5623.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6218.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10592\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atp synthase b chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p24539]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1970\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4374.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4126.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atp synthase beta chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p06576]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
869\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5595.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6173.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10322\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atp synthase coupling factor 6, mitochondrial precursor (ec 3.6.3.14) (f6). [source:swissprot;acc:p18859]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2893\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atp synthase coupling factor b, mitochondrial precursor. [source:swissprot;acc:q99766]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1507\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6152.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6610.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07439\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atp synthase delta chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p30049]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
811\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6000.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6655.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10917\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atp synthase f chain, mitochondrial (ec 3.6.3.14). [source:swissprot;acc:p56134]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2036\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6920.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7315.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05706\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atp synthase g chain, mitochondrial (ec 3.6.3.14) (atpase subunit g). [source:swissprot;acc:o75964]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2834\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atp synthase gamma chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p36542]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
824\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5657.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6263.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10702\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
atp synthase mitochondrial f1 complex assembly factor 2. [source:refseq;acc:nm\_145691]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1657\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5488.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5131.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06953\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/